Flagecidin

Flagecidin

22862-76-6

(-)-Anisomycin; (2R,3S,4S)-2-((4-Methoxyphenyl)methyl)-3,4-pyrrolidinediol 3-acetate; (2R,3S,4S)-2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate; (2R,3S,4S)-2-(p-Methoxyphenylmethyl)-3-acetoxy-4-hydroxypyrrolidine; 2-(p-Methoxybenzyl)-3,4-pyrrolidinediol 3-acetate; 2-p-Methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R,3S,4S)-; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2-alpha,3-alpha,4-beta))-; 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)-; 5-21-05-00523 (Beilstein Handbook Reference); AI3-50846; Antibiotic PA-106; BRN 0020705; EINECS 245-269-7; Flagecidin; NSC 147340; NSC 76712; NSC-76712; UNII-6C74YM2NGI; Upjohn 204t3; 1,4,5-Trideoxy-1,4-imino-5-(p-methoxyphenyl)-D-xylo-pentitol 3-acetate; 3,4-Pyrrolidinediol, 2-((4-methoxyphenyl)methyl)-, 3-acetate, (2R-(2alpha,3alpha,4beta))-; 3,4-Pyrrolidinediol, 2-(p-methoxybenzyl)-, 3-acetate, (2S,3R,4R)- (8CI); Anisomycin;

265.31

[C@H]1([C@@H]([C@H](CN1)O)OC(=O)C)Cc1ccc(cc1)OC

YKJYKKNCCRKFSL-RDBSUJKOSA-N

1S/C14H19NO4/c1-9(16)19-14-12(15-8-13(14)17)7-10-3-5-11(18-2)6-4-10/h3-6,12-15,17H,7-8H2,1-2H3/t12-,13+,14+/m1/s1

0.610

1.25E-10 cm3/molecule-sec

140.5 ° C

6550 mg/L